Adage Capital Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40.2M | Sell |
501,866
-1,452,765
| -74% | -$120M | 0.06% | 295 |
|
|
2025
Q4 | $167M | Buy |
1,954,631
+595,165
| +44% | +$48.8M | 0.25% | 67 |
|
|
2025
Q3 | $106M | Buy |
1,359,466
+485,649
| +56% | +$37.9M | 0.17% | 119 |
|
|
2025
Q2 | $68.3M | Buy |
873,817
+420,551
| +93% | +$31.4M | 0.12% | 175 |
|
|
2025
Q1 | $32.9M | Sell |
453,266
-770,627
| -63% | -$55.2M | 0.06% | 309 |
|
|
2024
Q4 | $90.6M | Buy |
1,223,893
+389,141
| +47% | +$27.2M | 0.16% | 120 |
|
|
2024
Q3 | $55.1M | Buy |
834,752
+185,089
| +28% | +$13.4M | 0.1% | 216 |
|
|
2024
Q2 | $60M | Sell |
649,663
-644,300
| -50% | -$57.1M | 0.11% | 188 |
|
|
2024
Q1 | $124M | Buy |
1,293,963
+834,818
| +182% | +$70.1M | 0.23% | 81 |
|
|
2023
Q4 | $35M | Buy |
+459,145
| New | +$31.9M | 0.07% | 281 |
|
|
2023
Q3 | – | Sell |
-415,805
| Closed | -$39.2M | – | 893 |
|
|
2023
Q2 | $39.2M | Sell |
415,805
-113,803
| -21% | -$9.89M | 0.09% | 242 |
|
|
2023
Q1 | $43.8M | Buy |
529,608
+135,742
| +34% | +$10.7M | 0.1% | 244 |
|
|
2022
Q4 | $29.4M | Sell |
393,866
-107,700
| -21% | -$8.3M | 0.07% | 322 |
|
|
2022
Q3 | $41.4M | Sell |
501,566
-96,000
| -16% | -$9.24M | 0.1% | 214 |
|
|
2022
Q2 | $56.8M | Sell |
597,566
-54,400
| -8% | -$5.63M | 0.13% | 165 |
|
|
2022
Q1 | $76.7M | Sell |
651,966
-13,300
| -2% | -$1.49M | 0.15% | 147 |
|
|
2021
Q4 | $86.2M | Sell |
665,266
-4,300
| -0.6% | -$502K | 0.16% | 144 |
|
|
2021
Q3 | $75.8M | Sell |
669,566
-6,200
| -0.9% | -$708K | 0.15% | 144 |
|
|
2021
Q2 | $70M | Sell |
675,766
-20,200
| -3% | -$1.9M | 0.14% | 157 |
|
|
2021
Q1 | $58.2M | Buy |
695,966
+4,000
| +0.6% | +$338K | 0.12% | 187 |
|
|
2020
Q4 | $63.1M | Sell |
691,966
-4,700
| -0.7% | -$390K | 0.14% | 168 |
|
|
2020
Q3 | $55.6M | Sell |
696,666
-18,285
| -3% | -$1.43M | 0.14% | 162 |
|
|
2020
Q2 | $49.4M | Sell |
714,951
-267,750
| -27% | -$19M | 0.13% | 184 |
|
|
2020
Q1 | $61.8M | Buy |
982,701
+462,378
| +89% | +$33.3M | 0.18% | 142 |
|
|
2019
Q4 | $40.5M | Sell |
520,323
-163,200
| -24% | -$12.7M | 0.1% | 243 |
|
|
2019
Q3 | $50.1M | Sell |
683,523
-74,307
| -10% | -$5.22M | 0.12% | 203 |
|
|
2019
Q2 | $46.7M | Sell |
757,830
-355,320
| -32% | -$21.5M | 0.12% | 217 |
|
|
2019
Q1 | $71M | Buy |
1,113,150
+500,646
| +82% | +$28.6M | 0.18% | 147 |
|
|
2018
Q4 | $31.3M | Sell |
612,504
-83,076
| -12% | -$4.2M | 0.09% | 256 |
|
|
2018
Q3 | $40.4M | Sell |
695,580
-820,500
| -54% | -$40.1M | 0.09% | 259 |
|
|
2018
Q2 | $73.6M | Sell |
1,516,080
-689,325
| -31% | -$32.2M | 0.17% | 160 |
|
|
2018
Q1 | $103M | Buy |
2,205,405
+562,029
| +34% | +$24.4M | 0.24% | 110 |
|
|
2017
Q4 | $61.7M | Buy |
1,643,376
+965,250
| +142% | +$35.4M | 0.14% | 186 |
|
|
2017
Q3 | $24.7M | Sell |
678,126
-905,877
| -57% | -$34.5M | 0.06% | 366 |
|
|
2017
Q2 | $62.4M | Buy |
1,584,003
+962,310
| +155% | +$35.1M | 0.15% | 183 |
|
|
2017
Q1 | $19.5M | Sell |
621,693
-299,595
| -33% | -$9.38M | 0.05% | 406 |
|
|
2016
Q4 | $28.8M | Sell |
921,288
-1,577,385
| -63% | -$51.1M | 0.08% | 302 |
|
|
2016
Q3 | $100M | Sell |
2,498,673
-683,100
| -21% | -$25.7M | 0.28% | 96 |
|
|
2016
Q2 | $106M | Sell |
3,181,773
-187,002
| -6% | -$6.4M | 0.29% | 94 |
|
|
2016
Q1 | $99.1M | Sell |
3,368,775
-414,525
| -11% | -$11.4M | 0.27% | 107 |
|
|
2015
Q4 | $99.6M | Buy |
3,783,300
+213,300
| +6% | +$5.54M | 0.26% | 115 |
|
|
2015
Q3 | $84.6M | Buy |
3,570,000
+1,068,000
| +43% | +$25.8M | 0.23% | 121 |
|
|
2015
Q2 | $59.4M | Buy |
2,502,000
+1,200,000
| +92% | +$27.1M | 0.15% | 196 |
|
|
2015
Q1 | $30.9M | Buy |
1,302,000
+307,200
| +31% | +$6.89M | 0.08% | 324 |
|
|
2014
Q4 | $21.1M | Buy |
994,800
+283,200
| +40% | +$5.69M | 0.05% | 395 |
|
|
2014
Q3 | $12.1M | Buy |
+711,600
| New | +$11.2M | 0.03% | 503 |
|
|
2013
Q4 | – | Sell |
-1,015,200
| Closed | -$11.8M | – | 696 |
|
|
2013
Q3 | $11.8M | Buy |
1,015,200
+462,000
| +84% | +$5.4M | 0.03% | 479 |
|
|
2013
Q2 | $6.2M | Buy |
+553,200
| New | +$6.55M | 0.02% | 571 |
|
Other funds holding EW
VCM
VPM
Adage Capital Partners's EW Position: Q1 2026 in Review
Adage Capital Partners reduced its Edwards Lifesciences (EW) stake by 74% in Q1 2026, selling an estimated $120M and leaving 501,866 shares worth $40.2M. The position accounts for 0.06% of the portfolio, ranked #295.
Adage Capital Partners first reported a position in EW in Q2 2013 and has held it in 48 quarters since. The position peaked at $167M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Adage Capital Partners held 501,866 shares of Edwards Lifesciences worth $40.2M as of Q1 2026.
- Adage Capital Partners sold 1,452,765 Edwards Lifesciences shares in Q1 2026, an estimated $120M.
- Edwards Lifesciences made up 0.06% of Adage Capital Partners's portfolio in Q1 2026, its #295 holding.
- Adage Capital Partners first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 48 quarters since.
- Adage Capital Partners's Edwards Lifesciences position peaked at $167M in Q4 2025.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.